Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training

Description

This pilot study will evaluate the cognitive and behavioral outcomes of using a novel, adaptive attention training in pediatric cancer survivors.

Conditions

Pediatric Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This pilot study will evaluate the cognitive and behavioral outcomes of using a novel, adaptive attention training in pediatric cancer survivors.

A Pilot Study of Assessing and Improving Cognition and Real-World Behavior in Pediatric Cancer Survivors

Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training

Condition
Pediatric Cancer
Intervention / Treatment

-

Contacts and Locations

San Francisco

Univeristy of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 7-17 at the time of enrollment.
  • 2. Able to understand study procedures and to comply with them for the entire length of the study.
  • 3. Ability of individual and legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  • 4. Normal or corrected-normal vision and hearing.
  • 5. English language fluency (minor participant and parent/guardian).
  • 6. Received radiation therapy to the brain or neck between age 7-17.
  • 7. Patients not on current cancer-related treatment (except supportive care) or those on other current treatments that would not hinder study participation. Patients currently on cancer-related treatments will be discussed with the study team (co-PI Mueller).
  • 1. Contraindication to any study-related procedure or assessment.
  • 2. Motor/perceptual difficulties that prevent computer or tablet use.
  • 3. Current cancer-related treatments that would impact the ability to participate in the study (e.g., current inpatient chemotherapy or intrathecal chemotherapy). Patients on other current treatments will be discussed with the study team (co-PI, Dr. Mueller)

Ages Eligible for Study

7 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Joaquin Anguera, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2025-05-31